PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models
European Journal of Cancer · 2026-11 · 248 · 117474
DOI: 10.1016/j.ejca.2026.117474 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Kulukian und 18 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kulukian, A., Bindman, N., Nesterova, A., Arakaki, A., Olson, D., Anderson, S., Mitchell, J., Trueblood, E., Magunda, F., Murray, M., Green, K., Wo, S., Alizadeh, K., Minussi, D. C., Zafra, C. D., Frantz, C., Jensen-Pergakes, K., Lyon, R., & Sandall, S. (2026). PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models. European Journal of Cancer, 248, 117474. https://doi.org/10.1016/j.ejca.2026.117474
Vancouver
Kulukian A, Bindman N, Nesterova A, Arakaki A, Olson D, Anderson S, et al. PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models. European Journal of Cancer. 2026;248:117474. doi:10.1016/j.ejca.2026.117474
BibTeX
@article{Kulukian2026,
author = {Kulukian, A. and Bindman, N. and Nesterova, A. and Arakaki, A. and Olson, D. and Anderson, S. and Mitchell, J. and Trueblood, E. and Magunda, F. and Murray, M. and Green, K. and Wo, S. and Alizadeh, K. and Minussi, D. Conterno and Zafra, C. De and Frantz, C. and Jensen-Pergakes, K. and Lyon, R. and Sandall, S.},
title = {PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117474},
doi = {10.1016/j.ejca.2026.117474}
}
EUVIMED